Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Amesite ( (AMST) ) has issued an update.
Amesite Inc. has entered into an underwriting agreement with Laidlaw & Company to issue and sell 1,201,667 shares of its common stock at $3.00 per share, aiming to raise approximately $3.6 million. The proceeds from the offering, which closed on January 8, 2025, will be used for general corporate purposes, capital expenditures, and working capital, potentially enhancing the company’s financial stability and supporting its strategic initiatives.
More about Amesite
Amesite Inc. is a pioneering technology company that specializes in the development and marketing of B2C and B2B AI-driven solutions. The company leverages its proprietary AI infrastructure to offer cutting-edge applications for both individual and professional needs, including NurseMagic™, a mobile app designed for health and care professionals to streamline nursing tasks and improve patient communication.
YTD Price Performance: -38.78%
Average Trading Volume: 66,256
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $10.78M
For a thorough assessment of AMST stock, go to TipRanks’ Stock Analysis page.
